We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. CDK5: an oncogene or an anti-oncogene: location location location

    Recent studies have uncovered various physiological functions of CDK5 in many nonneuronal tissues. Upregulation of CDK5 and/or its activator p35 in...

    Kumar Nikhil, Kavita Shah in Molecular Cancer
    Article Open access 23 November 2023
  2. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment

    Immune checkpoint inhibitors (ICIs) have revolutionized the clinical management of multiple tumours. However, only a few patients respond to ICIs,...

    Giulia Petroni, Aitziber Buqué, ... Lorenzo Galluzzi in Nature Reviews Drug Discovery
    Article 15 March 2022
  3. Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis

    Background

    Chronic inflammation causes bone destruction in middle ear cholesteatomas (MECs). However, the causes of their neoplastic features remain...

    Chisei Satoh, Koh-ichiro Yoshiura, ... Yoshihiko Kumai in BMC Medical Genomics
    Article Open access 15 November 2023
  4. BCLAF1 is Expressed as a Potential Anti-oncogene in Bile Duct Cancer

    Validating the role of BCLAF1 in the development of Bile Duct Cancer. Differential expression of BCLAF1 in Bile Duct Cancer and normal tissues was...

    Yutong Zhou, Xun Ran, Min Han in Biochemical Genetics
    Article 10 January 2024
  5. ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors

    Background

    ATM is a multifunctional serine/threonine kinase that in addition to its well-established role in DNA repair mechanisms is involved in a...

    Cristina Terlizzi, Viviana De Rosa, ... Silvana Del Vecchio in Cancer & Metabolism
    Article Open access 06 November 2023
  6. IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression

    Background

    Neuroblastoma is the most common solid tumor in infants accounting for approximately 15% of all cancer-related deaths. Over 50% of...

    Sven Hagemann, Danny Misiak, ... Stefan Hüttelmaier in Molecular Cancer
    Article Open access 29 May 2023
  7. Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma

    The biological functions of noncoding RNA N 6 -methyladenosine (m 6 A) modification remain poorly understood. In the present study, we depict the...

    Rui Li, Hongzhe Zhao, ... Jian Zheng in Nature Genetics
    Article 13 November 2023
  8. GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms

    Neoplasms originating from thymic T-cell progenitors and post-thymic mature T-cell subsets account for a minority of lymphoproliferative neoplasms....

    **angrong Geng, Chenguang Wang, ... Ryan A. Wilcox in Blood Cancer Journal
    Article Open access 04 November 2022
  9. TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence

    ERG translocations are commonly involved in the initiation of prostate neoplasia, yet previous experimental approaches have not addressed mechanisms...

    Lei Fang, Dongmei Li, ... Kathleen Kelly in Cancer Gene Therapy
    Article 07 April 2022
  10. AIP: A double agent? The tissue-specific role of AIP as a tumour suppressor or as an oncogene

    Aryl hydrocarbon receptor-interacting protein (AIP) is a co-chaperone to heat shock proteins and nuclear receptors. Loss-of-function heterozygote...

    Oliver Haworth, Márta Korbonits in British Journal of Cancer
    Article 05 September 2022
  11. Integrative analysis of m3C associated genes reveals METTL2A as a potential oncogene in breast Cancer

    RNA methylation modifications, especially m6A mRNA modification, are known to be extensively involved in tumor development. However, the relationship...

    Shuai Wang, Huiting Li, ... Zheng Li in Journal of Translational Medicine
    Article Open access 20 October 2022
  12. Long non-coding RNA XIST: a novel oncogene in multiple cancers

    Long non-coding RNA (lncRNA) X-inactive specific transcript (XIST) is an important lncRNA derived from the XIST gene in mammals. XIST is abnormally...

    Jun Yang, Manlong Qi, ... Kefeng Wang in Molecular Medicine
    Article Open access 20 December 2021
  13. GNA13 suppresses proliferation of ER+ breast cancer cells via ERα dependent upregulation of the MYC oncogene

    GNA13 (Gα13) is one of two alpha subunit members of the G12/13 family of heterotrimeric G-proteins which mediate signaling downstream of GPCRs. It is...

    Lalitha Vaishnavi Subramanyan, Suhail Ahmed Kabeer Rasheed, ... Patrick J. Casey in Breast Cancer Research
    Article Open access 04 July 2024
  14. Creatine Kinase-MM/Proto-oncogene Tyrosine-Protein Kinase Receptor as a Sensitive Indicator for Duchenne Muscular Dystrophy Carriers

    Duchenne muscular dystrophy (DMD), a lethal X-linked recessive genetic disease, is characterized by progressive muscle wasting which will lead to...

    Zhilei Zhang, Dongyang Hong, ... Zhengfeng Xu in Molecular Neurobiology
    Article 20 May 2024
  15. Identifying Genetic Signatures Associated with Oncogene-Induced Replication Stress in Osteosarcoma and Screening for Potential Targeted Drugs

    Osteosarcoma is the most common type of primary malignant bone tumor. Due to the lack of selectivity and sensitivity of chemotherapy drugs to tumor...

    Meng Gao, Weibo Liu, ... XueSong Zhang in Biochemical Genetics
    Article 06 September 2023
  16. Oncogene-mediated metabolic gene signature predicts breast cancer outcome

    Breast cancer remains the second most lethal cancer among women in the United States and triple-negative breast cancer is the most aggressive subtype...

    Merve Aslan, En-Chi Hsu, ... Tanya Stoyanova in npj Breast Cancer
    Article Open access 28 October 2021
  17. Oncogene SCARNA12 as a potential diagnostic biomarker for colorectal cancer

    Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive system, and represents a severe threat to the life and health of...

    Hong Zhang, **n Liu, ... Zhidong Wang in Molecular Biomedicine
    Article Open access 01 November 2023
  18. Plectin promotes tumor formation by B16 mouse melanoma cells via regulation of Rous sarcoma oncogene activity

    Background

    Melanoma is a malignant tumor characterized by high proliferation and aggressive metastasis. To address the molecular mechanisms of the...

    Kana Mizuta, Takuma Matsubara, ... Shoichiro Kokabu in BMC Cancer
    Article Open access 30 August 2022
  19. Chromothripsis followed by circular recombination drives oncogene amplification in human cancer

    The mechanisms behind the evolution of complex genomic amplifications in cancer have remained largely unclear. Using whole-genome sequencing data of...

    Carolina Rosswog, Christoph Bartenhagen, ... Matthias Fischer in Nature Genetics
    Article 15 November 2021
  20. Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy

    Background

    The combination of radiotherapy and immunotherapy (immunoradiotherapy) has been increasingly used for treating a wide range of cancers....

    Yun Hu, Alexey Revenko, ... James W. Welsh in Journal of Experimental & Clinical Cancer Research
    Article Open access 06 March 2024
Did you find what you were looking for? Share feedback.